A possible role for the thyrotropin receptor in thyroid-associated ophthalmopathy

References

• Burman K D, Baker J R, Jr. Immune mechanisms in Graves' disease. Endocr Rev 1985; 6: 183–232
   PubMed Web of Science ®Google Scholar
• Nagayama Y, Kaufman K, Seto P, Rapoport B. Molecular cloning, sequencing and functional expression of the cDNA for the human thyrotropin receptor. Biochem Biophys Res Commun 1989; 165: 1184–1190
   PubMed Web of Science ®Google Scholar
• Bahn R S, Heufelder A E. Mechanisms of disease: pathogenesis of Graves' ophthalmopathy. N Engl J Med 1993; 329: 1468–1475
   PubMed Web of Science ®Google Scholar
• Campbell R. Pathology of Graves' ophthalmopathy. The Eye in Orbit in Thyroid Disease, C A Gorman, R A Waller, J A Dyer. Raven Press, New York 1984; 25–31
   Google Scholar
• Bahn R S, Heufelder A E. Retroocular fibroblasts: important effector cells in Graves' ophthalmopathy. Thyroid 1992; 2: 89–94
   PubMed Web of Science ®Google Scholar
• Heufelder A E, Bahn R S. Detection and localization of cytokine immunoreactivity in retroocular connective tissue in Graves' ophthalmopathy. Eur J Clin Invest 1993; 23: 10–17
   PubMed Web of Science ®Google Scholar
• Weetman A P, Cohen S, Gatter K C, Fells P, Shine B. Immunohistochemical analysis of the retrobulbar tissues in Graves' ophthalmopathy. Clin Exp Immunol 1989; 75: 222–227
   PubMed Web of Science ®Google Scholar
• Korducki J M, Loftus S J, Bahn R S. Stimulation of glycosaminoglycan production in cultured human retroocular fibroblasts. Invest Ophthalmol Vis Sci 1992; 33: 2037–2042
   PubMed Web of Science ®Google Scholar
• Smith T J, Bahn R S, Gorman C A, Cheavens M. Stimulation of glycosaminoglycan accumulation by interferon gamma in cultured human retroocular fibroblasts. J Clin Endocrinol Metabol 1991; 72: 1169–1171
   PubMed Web of Science ®Google Scholar
• Marcocci C, Bartalena L, Bogazzi F M, Panicucci M, Pinchera A. Studies on the occurrence of ophthalmopathy and Graves' disease. Acta Endocrinol (Copenh) 1989; 120: 473–478
   PubMedGoogle Scholar
• Werner S C, Coleman D J, Franzen L A. Ultrasonographic evidence of a consistent orbital involvement in Graves' disease. N Engl J Med 1974; 290: 1447–1450
   PubMed Web of Science ®Google Scholar
• Salvi M, Zhang Z-G, Haegert D, Woo M, Liberman A, Cadarso L, Wall J R. Patients with endocrine ophthalmopathy not associated with overt thyroid disease, have multiple thyroid immunological abnormalities. J Clin Endocrinol Metabol 1990; 70: 89–94
   PubMed Web of Science ®Google Scholar
• Morris J C, III, Hay I D, Nelson R E, Jiang N AIS. Clinical utility of thyrotropin receptor antibody assays: comparison of radioreceptor and bioassay methods. Mayo Clin Proc 1988; 63: 707–717
   PubMed Web of Science ®Google Scholar
• Teng C S, Yeo P PB. Ophthalmic Graves' disease: natural history and detailed thyroid function studies. Br Med J 1977; 1: 273–275
   PubMedGoogle Scholar
• Murakami M, Mori M. Identification of immunogenic regions in human thyrotropin receptor for immunoglobulin G of patients with Graves' disease. Biochem Biophys Res Commun 1990; 171: 512–518
   PubMed Web of Science ®Google Scholar
• Martin A, Davies T F. T cells and human thyroid disease: emerging data show lack of need to invoke suppressor T cell problems. Thyroid 1992; 2: 247–261
   PubMed Web of Science ®Google Scholar
• Bahn R S, Garrity J A, Bartley G B, Gorman C A. Diagnostic evaluation of Graves' ophthalmopathy. Endocrinol Metabol Clin North Am 1988; 17: 527–545
   PubMed Web of Science ®Google Scholar
• Wortsman J, Dietrich J, Traycoff R B, Stone S. Preradial myxedema in thyroid disease. Arch Dermatol 1981; 117: 635–638
   PubMedGoogle Scholar
• Smith T J, Bahn R S, Gorman C A. Connective tissue, glycosaminoglycans, and diseases of the thyroid. Endocr Rev 1989; 10: 366–391
   PubMed Web of Science ®Google Scholar
• Salvi M, De Chiara F, Gardini E, et al. Echographic diagnosis of pretibial myxedema in patients with autoimmune thyroid disease. Eur J Endocrinol 1994; 131: 113–119
   PubMedGoogle Scholar
• Fatourechi V, Pajouhi M, Fransway A F. Dermopathy of Graves' disease (pretibial myxedema). Medicine 1994; 73: 1–7
   PubMed Web of Science ®Google Scholar
• Grubeck-Loebenstein B, Trieb K, Sztankay A, Holter W, Anderl H, Wick G. Retrobulbar T cells from patients with Graves' ophthalmopathy are CD8+ and specifically recognize autologous fibroblasts. J Clin Invest 1994; 93: 2738–2743
   PubMed Web of Science ®Google Scholar
• Chelly J, Concordet J P, Kaplan J C, Kahn A. Illegitimate transcription: transcription of any gene in any cell type. Proc Natl Acad Sci USA 1988; 86: 2617–2621
   Google Scholar
• Heufelder A E, Dutton C M, Sarkar G, Donovan K A, Bahn R S. Detection of TSH receptor RNA in cultured fibroblasts from patients with Graves' ophthalmopathy and pretibial dermopathy. Thyroid 1993; 3: 297–300
   PubMed Web of Science ®Google Scholar
• Feliciello A, Porcellini A, Ciullo I, Bonavolontà G, Avvedimento E V, Fenzi G. Expression of thyrotropinreceptor mRNA in healthy and Graves' disease retro-orbital tissue. Lancet 1993; 342: 337–338
   PubMed Web of Science ®Google Scholar
• Paschke R, Elisei R, Vassart G, Ludgate M. Lack of evidence supporting the presence of mRNA for the thyrotropin receptor in extraocular muscle. J Endocrinol Invest 1993; 16: 329–332
   PubMedGoogle Scholar
• Paschke R, Metcalfe A, Alcalde L, Vassart G, Weetman A, Ludgate M. Presence of nonfunctional thyrotropin receptor variant transcripts in retroocular and other tissues. J Clin Endocrinol Metabol 1994; 79: 1232–1233
   PubMedGoogle Scholar
• Mengistu M, Lukes Y G, Nagy E V, Burch H B, Carr F E, Lahiri S, Burman K D. TSH receptor gene expression in retroocular fibroblasts. J Endocrinol Invest 1994; 17: 437–441
   PubMed Web of Science ®Google Scholar
• Chang T-C, Wu S-L, Hsiao Y-L. TSH and TSH receptor antibody binding sites in fibroblasts of pretibial myxedema are related to the extracellular domain of entire TSH. Clin Immunol Immunopathol 1994; 71: 113–120
   PubMedGoogle Scholar
• Roselli-Rehfuss L, Robbins L S, Cone R D. Thyrotropin receptor messenger ribonucleic acid is expressed in most brown and white adipose tissues in the guinea pig. Endocrinology 1992; 130: 1857–1861
   PubMed Web of Science ®Google Scholar
• Endo T, Ohno M, Kotani S, Gunjik K, Onaya T. Thyrotropin receptor in non-thyroid tissues. Biochem Biophys Res Comm 1993; 190: 774–779
   PubMedGoogle Scholar
• Endo T, Ohta K, Haraguchi K, Onaya T. Cloning and functional expression of a thyrotropin receptor cDNA from rat fat cells. J Biol Chem 1995; 270: 10833–10837
   PubMed Web of Science ®Google Scholar
• Burch H B, Sellitti D, Barnes S G, Nagy E V, Bahn R S, Burman K D. Thyrotropin receptor antisera for the detection of immunoreactive protein species in retroocular fibroblasts obtained from patients with Graves' ophthalmopathy. J Clin Endocrinol Metabol 1994; 78: 1384–1391
   PubMedGoogle Scholar
• Bolonkin D, Tate R L, Luber J H, Kohn L D. Experimental exophthalmos. Binding of thyrotropin and an exophthalmogenic factor derived from thyrotropin retro-orbital plasma membranes. J Biol Chem 1975; 250: 6516–6521
   PubMedGoogle Scholar
• Davies T F, Teng C S, McLachlan S M, Rees Smith B, Hall R. Thyrotropin receptors in adipose tissue, retroorbital tissue and lymphocytes. Mol Cell Endocrinol 1978; 9: 303–310
   PubMedGoogle Scholar
• Ilda Y, Amir S M, Ingbar S H. Stabilization, partial purification, and characterization of thyrotropin receptors in solubilized guinea pig fat cell membranes. Endocrinology 1987; 121: 1627–1636
   PubMedGoogle Scholar
• Perros P, Kendall-Taylor P. Demonstration of thyrotropin-binding sites in orbital connective tissue: possible role in the pathogenesis of thyroidassociated ophthalmopathy. J Endocrinol Invest 1994; 17: 163–170
   PubMedGoogle Scholar
• Rottela C M, Zonefrati R, Toccafondi R, Valente W A, Kohn L D. Ability of monoclonal antibodies to the thyrotropin receptor to increase collagen synthesis in human fibroblasts: An assay which appears to measure exophthalmogenic immunoglobulins in Graves' sera. J Clin Endocrinol Metabol 1986; 62: 357–367
   PubMedGoogle Scholar
• Westermark K, Lilja K, Karlsson F A. Effects of sera and immunoglobulin preparations from patients with endocrine ophthalmopathy on the production of hyaluronate and the incorporation of tritiated thymidine in fibroblasts. Acta Endocrinol 1989; 121: 85–89
   Google Scholar
• Heufelder A E, Bahn R S. Graves' immunoglobulins and cytokines stimulate the expression of intercellular adhesion molecule-1 (ICAM-1) in cultured Graves' orbital fibroblasts. Eur J Clin Invest 1992; 22: 529–537
   PubMed Web of Science ®Google Scholar
• Heufelder A E, Bahn R S. Evidence for the presence of a functional TSH receptor in retroocular fibroblasts from patients with Graves' ophthalmopathy. Exp Clin Endocrinol 1992; 100: 62–67
   PubMedGoogle Scholar
• Atwa M A, Smallridge R C, Gist I D, Abo-Hashem E M, El-Kannishy M H, Burman K D. Effects of bradykinin and TSH on phospholipase C and A2 systems in retroocular fibroblasts obtained from patients with Graves' ophthalmopathy. Thyroid 1995; 5: S-13, (Abstract)
   PubMedGoogle Scholar
• Bahn R S, Dutton C M, Heufelder A E, Sarkar G. A genomic point mutation in the extracellular domain of the thyrotropin receptor in patients with Graves' ophthalmopathy. J Clin Endocrinol Metabol 1994; 78: 256–260
   PubMedGoogle Scholar
• Bohr U RM, Behr M, Loos U. A heritable point mutation in an extracellular domain of the TSH receptor involved in the interaction with Graves' immunoglobulins. Biochem Biophys Acta 1993; 1216: 504–508
   PubMedGoogle Scholar
• Cuddihy R M, Dutton C M, Bahn R S. A polymorphism in the extracellular domain of the thyrotropin receptor is highly associated with autoimmune thyroid disease in females. Thyroid 1995; 5: 89–95
   PubMed Web of Science ®Google Scholar